Takeda Says to Buy Millennium Pharma For $8.8 Billion
TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T>
said it would buy U.S. firm Millennium Pharmaceuticals Inc
<MLNM.O> for $8.8 billion to boost its cancer drug business, in
the biggest overseas acquisition by a Japanese drug maker.